Johnson & Johnson Medtech announced the American Mentor Memorygel launch improves breast implants, with the aim of filling a void in the integral attention of breast cancer for women who have undergone a mastectomy.
Designed for primary or review reconstruction after a mastectomy, the United States food and medication administration (FDA), mentor, memory, breast implants specifically improve women with larger breasts, which offer sizes from 930 cc to 1445 cc and give surgeons the ability to deliver more personalized results without competing with aesthetic results.
Breast implants address the needs of approximately 15% of patients after mastectomy that previously lacked access to adequate -size implants for reconstruction.
“Johnson & Johnson Medtech is fulfilling our promise to make breast reconstruction more inclusive, supportive and empowering for all Johnson & Johnson & Johnson & Johnson & Johnson & Johnson’s Construction.” Too many women have run out of options that helped them achieve the desired results. The availability of Memorygel Enhany Implants brings us closer to addressing this gap, because each woman deserves access and hersts “.” “”
Offer choice for patients after mastectomy
With breast cancer rates that continue to increase in the US, more than 246,000 women undergo a mastectomy every year as part of breast cancer treatment or prevention. Breast reconstruction offers thesis women the option to rebuild their breasts after surgery using implants, restoring the shape and volume.
Without an appropriate implant for size, patients can face symmetry problems, subopymal aesthetic results or the need for additional surgery to achieve the desired results. Until now, the largest warning implant was 800 cc, which makes it difficult for patients with larger body frames or extensive tissue extraction to reach proportional results and caused lower reconstruction rates.
Memorygel implants improve the same formulation of patented gel, softness and retention so that the portfolio of existing mentors and now are greedy in larger sizes with an expanded range of grassroots, projections and patumes. The Mentor Products Family includes Memorygel Implant Implants, CPX4 Plus improve breast tissue expansters and Memorygel breast implants, designed to work together to support a complete reconstruction experience.
“Despite being a standard part of the care after mastectomy, the reconstruction options have not maintained the rhythm of the diverse needs of the population of patients today,” says Mark Migliori, MD, facs, plastic surgeon certified by the Board, Minnesota, in a performance performed. “For patients who require a greater volume implant than what was previously aviaxable, they now have an option that helps them be complete again.”
Mentor Memorygel Enhance Breast Implants Were Approved By The Us Fda For Primary and Review Inviction in November 2024. Three-Year Data from The Athena Study, The Largest Multicenter Reconstruction for Reconstruction for Reconstruction for Reconstruction for Reconstruction for Reconstruction for Reconstruction for Reconstructy and Recytyction for Reconstruction for Reconstructy and Reconstruction for Reconstructy and Recysty for Reconstructy and Reconstructy and Reconstructy and Reconstructy and Reconstructy and Restructy Reconstructy and reconstructy and reconstructy and reconstructy and reconstructy and reconstruction and reconstruction and reconsty structure and reconstructy from Construction Larger Implants, including 96% Overall Patient satisfaction, Low Complication Rates, and significant Improvements in Physical, Psychosocial, and sexual welfare.
Photo legend: Memorygel Best
Photo credit: Johnson and Johnson
